Table 3.
Overall | La cohort | Cb cohort | Group differences using Wilcoxon signed-rank test | |
Total patient burden (scores 1–7) | ||||
WB-MRIc | 2.21 (1.1) | 2.33d (0.94) | 2.09e (1.18) | p < 0.001d |
CT/PET-CTc | 1.87 (0.98) | 2.05d (0.82) | 1.70e (1.1) | p < 0.001e |
Discomfort sub-scale (1–7) | ||||
WB-MRIc | 2.51 (1.26) | 2.65d (1.14) | 2.30e (1.22) | p < 0.001d |
CT/PET-CTc | 1.83 (1.05) | 2.04d (.90) | 1.63e (1.15) | p < 0.001e |
Worry subscale (1–7) | ||||
WB-MRIc | 2.47 (1.32) | 2.62d (1.15) | 2.23e (1.31) | p = 0.208d |
CT/PET-CTc | 2.24 (1.23) | 2.52d (1.15) | 2.00e (1.28) | p = 0.041e |
Satisfaction subscale (1–7) | ||||
WB-MRIc | 6.25 (1.06) | 6.27d (0.85) | 6.26e (1.23) | p = 0.036d |
CT/PET-CTc | 6.49f (0.89) | 6.43d (0.76) | 6.53e (1.01) | p < 0.001e |
WB-MRI, whole body MRI.
Numbers are mean (SD).
Non-small cell lung cancer, WB-MRI vs PET-CT.
Colorectal cancer, WB-MRI vs CT.
Missing data greater than 5%.
Comparison between WB-MRI and PET-CT (Lung).
Comparison between WB-MRI and CT (Colorectal).